Anti-VPS35 Antibody [10A8]

(No reviews yet) Write a Review
SKU:
STMA00211
Antibody Type:
Monoclonal
Applications:
WB
Applications:
ICC/IF
Applications:
IP
Applications:
IHC
Reactivity:
Human
Reactivity:
Mouse
Reactivity:
Rat
Host Species:
Mouse
Isotype:
IgG2a
  • Immunohistochemistry analysis using Mouse Anti-VPS35 Monoclonal Antibody, Clone 10A8 (STMA00211). Tissue: Thyroid Cancer. Species: Human. Primary Antibody: Mouse Anti-VPS35 Monoclonal Antibody (STMA00211) at 1:100 for Overnight at 4C, then 30 min at 37C. Secondary Antibody: Goat Anti-Mouse IgG (H+L): FITC for 45 min at 37C. Counterstain: DAPI for 3 min at RT. Magnification: 10X.
  • Immunocytochemistry/Immunofluorescence analysis using Mouse Anti-VPS35 Monoclonal Antibody, Clone 10A8 (STMA00211). Tissue: A549 cells. Species: Human. Primary Antibody: Mouse Anti-VPS35 Monoclonal Antibody (STMA00211) at 1:5 (tissue culture supernatant). Secondary Antibody: Donkey anti-mouse: Alexa Fluor 594 at 1:4000 in 0.2% BSA PBS. Counterstain: DAPI. Localization: Vesicles. A) VPS35 KO A549 cells B) WT A549 cells.
  • Immunocytochemistry/Immunofluorescence analysis using Mouse Anti-VPS35 Monoclonal Antibody, Clone 10A8 (STMA00211). Tissue: A549 WT, VPS35 KO cells. Species: Human. Primary Antibody: Mouse Anti-VPS35 Monoclonal Antibody (STMA00211). Secondary Antibody: Donkey Anti-Mouse AlexaFluor 594. Clone can detect VPS35 at 1/2000 concentration.
  • Immunoprecipitation analysis using Mouse Anti-VPS35 Monoclonal Antibody, Clone 10A8 (STMA00211). Tissue: A549 cells. Species: Human. Primary Antibody: Mouse Anti-VPS35 Monoclonal Antibody (STMA00211). 500 µL cell culture supernatants were incubated with 10 µL of Protein A/G resin beads for 1 hour at 4⁰C. STMA00211 clone 10A8 depletes VPS35 from the A549 cell extract.
  • Immunoprecipitation analysis using Mouse Anti-VPS35 Monoclonal Antibody, Clone 10A8 (STMA00211). Tissue: A549 cells. Species: Human. Primary Antibody: Mouse Anti-VPS35 Monoclonal Antibody (STMA00211).
  • Western Blot analysis of Human, Mouse A549, MEF showing detection of VPS35 protein using Mouse Anti-VPS35 Monoclonal Antibody, Clone 10A8 (STMA00211). Lane 1: Molecular Weight Ladder. Lane 2: VPS35 KO A549 cells. Lane 3: mouse embryonic fibroblast cells. Load: 8 µg each A549 and MEF. Primary Antibody: Mouse Anti-VPS35 Monoclonal Antibody (STMA00211) at 1:5 (tissue culture supernatant).
  • Mouse Anti-VPS35 Antibody [10A8] used in Western Blot (WB) on Human SH-SY5Y (STMA00211)
  • Immunoprecipitation analysis using Mouse Anti-VPS35 Monoclonal Antibody, Clone 10A8 (STMA00211). Tissue: A549 cells. Species: Human. Primary Antibody: Mouse Anti-VPS35 Monoclonal Antibody (STMA00211). Three amounts of STMA00211 (3, 1 and 0.3 ug) were non-covalently coupled to 10uL of A/G sepharose beads for 1 hour at 4°C and next incubated with 250ug of A549 lysate for 2 hours at 4°C.
Frequently bought together:

Description

VPS35 Antibody [10A8]

VPS35 Antibody [10A8] is a mouse monoclonal antibody directed against VPS35, offered by Assay Genie for research applications. Reported applications include WB, ICC/IF, IP and IHC. Reported reactivity: Human, Mouse and Rat. Supplied as IgG2a, purified by Protein G.

Vacuolar Protein Sorter 35 (VPS35) is a core component of the retromer complex, a critical intracellular trafficking system responsible for the endosome-to-Golgi retrieval of membrane proteins. This pathway is essential for maintaining protein homeostasis, synaptic function, and neuronal survival. Mutations in VPS35—most notably the D620N variant—have been directly linked to familial and sporadic forms of Parkinson’s disease (PD). These mutations impair retromer function, leading to disrupted recycling of key neuronal receptors and transporters. Dysfunctional VPS35 also contributes to mitochondrial fragmentation, oxidative stress, and impaired autophagy—cellular processes that are central to the pathogenesis of neurodegenerative diseases. Beyond Parkinson’s, VPS35 dysfunction has been implicated in Alzheimer’s disease and other proteinopathies, where it affects the trafficking of amyloid precursor protein (APP) and tau. Its role in regulating endosomal sorting and mitochondrial dynamics positions VPS35 as a critical node in the cellular pathways that maintain neuronal integrity. As a result, VPS35 is emerging as a promising therapeutic target in neurodegenerative disease research. Restoring or enhancing retromer function may offer novel strategies to counteract protein misfolding, synaptic loss, and neuroinflammation. This antibody is also available conjugated to ATTO 390, ATTO 488, ATTO 594, APC, Biotin, FITC, HRP, PerCP and RPE. Supplied in 100 µg. For research use only; not for diagnostic or therapeutic procedures.

View AllClose

0 Reviews

View AllClose